AMH and cancer: As well, our study supports the finding of the Reproductive Window Study, a cross-sequential study of the ovarian function of 763 female AYA survivors in California and Texas, which reported that younger age at cancer treatment was associated with higher long-term trajectories of ovarian function as measured by levels of the anti-Müllerian hormone (AMH) [15].